TechNavio today launched its report Global Life Science and Chemical Instrumentation Market 2012-2016 based on an in-depth analysis covering the Americas, and the EMEA and APAC regions. The report aims to aid decision makers’ understanding of the present and future landscape of the market.
Commenting on the report, an analyst from TechNavio’s Healthcare team said: ”Increasing outsourcing activities is one of the emerging trends in the Global Life Science and Chemical Instrumentation market. Over the years, a large number of drug manufacturers have been outsourcing their drug development processes to contract research organizations. This is because outsourcing reduces manufacturing and distribution costs, ensures quality of services, and reduces lead time. In addition, it helps the sourcing companies to manage product demand and to concentrate on other competencies such as innovation and brand building. On this front, the Asian and Latin American countries are experiencing high growth. For instance, one of the most preferred locations for outsourcing is Singapore because it is known for its strong intellectual property laws, excellent supply chain, and wide logistics connectivity. Moreover, it is considered a major base for setting up biotechnology and pharmaceutical manufacturing companies because of favorable tax incentives.”
According to the report, the need to optimize resources is one of the major drivers in the Global Life Science and Chemical Instrumentation market. The growing demand for effective diagnosis of disease-related issues has led companies to invest in high-sensitivity lab testing and developing generic drugs. This has led to an increase in the sales of analytical, separation, and other research-related instruments and consumables which are used in genomic and proteomic studies. In addition, authenticate research analysis for the development of efficient treatment methodologies and drug discovery has also influenced the growth of the sales of life science and chemical instruments.
Further, the report states that intense competition among vendors is one of the major challenges in the Global Life Science and Chemical Instrumentation Market.
The report also includes a discussion of the key vendors operating in this market. The key vendors dominating this market space are Agilent Technologies Inc., Life Technologies Corp., Roche Holding Ltd., and Thermo Fischer Scientific Inc. The other vendors mentioned in the report are Danaher Corp., Shimadzu Corp., Bio Rad Laboratories Inc., Illumina Inc., Affymetrix Inc., GE Healthcare Ltd., Perkin Elmer Inc., Siemens Healthcare, Abbott Laboratories, Hitachi High-technologies Corp., RainDance Technologies Inc., Tecan Group Ltd., Eppendorf AG, Genia Corp., and Oxford Nanopore Technologies Ltd.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors. For further information on this report, please visit https://www.technavio.com/content/global-life-science-and-chemical-instru…
TechNavio, the market research platform of Infiniti Research Ltd., publishes periodic market research reports on niche and emerging technologies. For more information on our Healthcare market research, please visit https://www.technavio.com/healthcare
Follow us on Twitter @ Technavio
TechNavio Announces the Publication of its Research Report – Global Life Science and Chemical Instrumentation Market 2012-2016
